Global Non-animal Capsule Market Size By Type (Type A (pH-9, Skin)), By Application (Pharmaceutical, Health Supplements), By Region, And Segment Forecasts, 2023 to 2032

The Global Non-animal Capsule Market was valued at USD 3.2 billion in 2023 and is projected to reach USD 6.1 billion by 2031, growing at a CAGR of 8.3% during the forecast period from 2023 to 2031. Non-animal capsules, commonly made from hydroxypropyl methylcellulose (HPMC) and pullulan, are witnessing a surge in demand due to increasing consumer preference for plant-based and vegan-friendly health supplements. As the nutraceutical, pharmaceutical, and functional food industries expand, non-animal capsules offer a sustainable and allergen-free alternative to gelatin capsules, catering to the growing population seeking ethical, dietary, and religious compliance.

Drivers:

1. Rising Vegan and Vegetarian Population:

With more consumers shifting towards plant-based lifestyles, the demand for animal-free pharmaceutical and nutraceutical products is significantly increasing. Non-animal capsules align with vegan dietary standards, accelerating their market adoption.

2. Clean Label and Transparency Trends:

Consumers are increasingly seeking transparency in product ingredients. Non-animal capsules offer a clean-label advantage, being free from animal derivatives, allergens, and GMOs, making them ideal for health-conscious buyers.

3. Expansion of Nutraceuticals and Dietary Supplements Industry:

The booming global wellness industry is fueling the demand for capsules used in the delivery of herbal extracts, vitamins, and probiotics—segments where non-animal capsules are increasingly preferred due to their stability and neutral taste.

Restraints:

1. Higher Manufacturing Costs Compared to Gelatin Capsules:

Production of non-animal capsules involves cost-intensive raw materials and complex manufacturing processes, making them more expensive than traditional gelatin capsules, which can affect adoption in cost-sensitive markets.

2. Limited Awareness in Developing Regions:

While the trend is gaining traction in developed economies, lack of awareness and minimal product differentiation in developing regions could pose a challenge to market penetration.

Opportunity:

1. Growth in Halal and Kosher-Certified Products:

The increasing demand for religiously compliant dietary supplements in Muslim and Jewish communities is providing a strong growth opportunity for non-animal capsule manufacturers.

2. Technological Advancements in Capsule Delivery Systems:

Innovations in capsule shell formulation—such as delayed-release, enteric-coating, and enhanced bioavailability—present opportunities for non-animal capsules to expand into advanced pharmaceutical applications.

Market by System Type Insights:

Based on system type, the HPMC Capsule segment accounted for the largest market share in 2023. HPMC capsules are favored due to their versatility, compatibility with a wide range of formulations, and ability to withstand humid conditions. The Pullulan Capsule segment is expected to register the fastest growth during the forecast period, driven by its completely natural and fermentation-derived base, appealing to strict vegan and organic product users.

Market by End-use Insights:

The Nutraceuticals segment held the dominant share in 2023, driven by the widespread usage of non-animal capsules in dietary supplements, probiotics, and herbal extracts. The Pharmaceutical segment is rapidly catching up due to the increased acceptance of plant-based formulations for ethical and allergen-free drug delivery.

Market by Regional Insights:

North America emerged as the leading region in 2023, supported by strong consumer awareness, growing vegan population, and strict regulatory support for plant-based labeling. Asia-Pacific is anticipated to witness the fastest growth rate, particularly in India, China, and Japan, owing to rising disposable income, increasing demand for clean-label health products, and expanding nutraceutical manufacturing bases.

Competitive Scenario:

Key players in the global non-animal capsule market include Capsugel (Lonza Group), ACG Worldwide, Qualicaps, Roxlor, CapsCanada, Sunil Healthcare Ltd, Healthcaps India Ltd, Suheung Co., Ltd., Hunan Er-Kang Pharmaceutical Co., Ltd., and Natural Capsules Ltd. These companies are focusing on product innovation, capacity expansion, and partnerships to enhance market share.

In 2023, Lonza Group introduced next-gen HPMC capsules with enhanced bioavailability for targeted nutraceutical delivery.

In 2024, ACG launched a vegan capsule range designed specifically for moisture-sensitive formulations, gaining popularity among probiotic manufacturers.

Qualicaps announced an R&D collaboration in 2025 to develop sustained-release non-animal capsules for pediatric drug delivery.

Scope of Work – Global Non-animal Capsule Market

Report Metric Details

Market Size (2023) USD 3.2 billion

Projected Market Size (2031) USD 6.1 billion

CAGR (2023-2031) 8.3%

Market Segments By System Type (HPMC, Pullulan), By End-use (Nutraceuticals, Pharmaceuticals), By Region

Growth Drivers Rising vegan population, clean-label trends, nutraceutical sector growth

Opportunities Halal/kosher product demand, capsule delivery innovations

Key Market Developments:

March 2023: Roxlor launched a new line of non-animal capsules with enteric-coating for improved release control in herbal therapies.

October 2024: Healthcaps India expanded its manufacturing unit to meet the surge in global demand for plant-based capsules.

January 2025: Suheung Co., Ltd. introduced biodegradable capsule variants targeting the sustainable packaging segment of pharma products.

FAQs:

1) What is the current market size of the Global Non-animal Capsule Market?

The Global Non-animal Capsule Market was valued at USD 3.2 billion in 2023.

2) What is the major growth driver of the Global Non-animal Capsule Market?

The major driver is the rising global demand for vegan, clean-label, and allergen-free supplement solutions.

3) Which is the largest region during the forecast period in the Global Non-animal Capsule Market?

North America is the largest region due to high consumer awareness and favorable regulatory environments.

4) Which segment accounted for the largest market share in the Global Non-animal Capsule Market?

The HPMC Capsule segment accounted for the largest market share in 2023.

5) Who are the key market players in the Global Non-animal Capsule Market?

Key players include Lonza Group, ACG Worldwide, Qualicaps, Roxlor, CapsCanada, and others.